Use of formative research in developing a knowledge translation approach to rotavirus vaccine introduction in developing countries
- PMID: 17919334
- PMCID: PMC2173895
- DOI: 10.1186/1471-2458-7-281
Use of formative research in developing a knowledge translation approach to rotavirus vaccine introduction in developing countries
Abstract
Background: Rotavirus gastroenteritis is the leading cause of diarrheal disease mortality among children under five, resulting in 450,000 to 700,000 deaths each year, and another 2 million hospitalizations, mostly in the developing world. Nearly every child in the world is infected with rotavirus at least once before they are five years old. Vaccines to prevent rotavirus or minimize its severity are now becoming available, and have already been introduced into the public vaccine programs of several Latin American countries. The World Health Organization (WHO) has made rotavirus vaccine introduction in developing countries a high priority. The WHOs Guidelines for Vaccine Introduction indicates that a key determinant to achieving vaccine introduction is the public health priority of the disease, suggesting that where the disease is not a priority uptake of the vaccine is unlikely. WHO recommends conducting a qualitative analysis of opinions held by the public health community to determine the perceptions of the disease and the priority given to the vaccine.
Methods: This paper presents the formative research results of a qualitative survey of public health providers in five low- and middle-income countries to determine if and to what degree rotavirus is perceived to be a problem and the priority of a vaccine. Open-ended surveys were carried out through focus group discussions and one-on-one interviews.
Results: Researchers discovered that in all five countries knowledge of rotavirus was extremely low, and as a result was not considered a high priority. However, diarrhea among young children was considered a high priority among public health providers in the three poorest countries with relatively high levels of child mortality: India, Indonesia, and Nicaragua.
Conclusion: In the poorest countries, advocacy and communication efforts to raise awareness about rotavirus sufficient for prioritization and accelerated vaccine introduction might benefit from a knowledge translation approach that delivers information and evidence about rotavirus through the broader context of diarrheal disease control, an existing priority, and including information about other new interventions, specifically low-osmolarity oral rehydration solution and zinc treatment.
Figures
Similar articles
-
Rotavirus vaccines: targeting the developing world.J Infect Dis. 2005 Sep 1;192 Suppl 1:S160-6. doi: 10.1086/431504. J Infect Dis. 2005. PMID: 16088799
-
Rotavirus vaccines and vaccination in Latin America.Rev Panam Salud Publica. 2000 Nov;8(5):305-31. doi: 10.1590/s1020-49892000001000002. Rev Panam Salud Publica. 2000. PMID: 11190969 Review.
-
A review of rotavirus vaccine use in Asia and the Pacific regions: challenges and future prospects.Expert Rev Vaccines. 2021 Dec;20(12):1499-1514. doi: 10.1080/14760584.2020.1853532. Epub 2021 Apr 20. Expert Rev Vaccines. 2021. PMID: 33275065 Review.
-
RotaTeq: Progress toward developing world access.J Infect Dis. 2010 Sep 1;202 Suppl:S87-92. doi: 10.1086/653546. J Infect Dis. 2010. PMID: 20684723
-
Knowledge and attitudes towards rotavirus diarrhea and the vaccine amongst healthcare providers in Yogyakarta Indonesia.BMC Health Serv Res. 2015 Nov 30;15:528. doi: 10.1186/s12913-015-1187-3. BMC Health Serv Res. 2015. PMID: 26621140 Free PMC article.
Cited by
-
Comparison of impact and cost-effectiveness of rotavirus supplementary and routine immunization in a complex humanitarian emergency, Somali case study.Confl Health. 2015 Feb 9;9:5. doi: 10.1186/s13031-015-0032-y. eCollection 2015. Confl Health. 2015. PMID: 25691915 Free PMC article.
-
Improving rotavirus vaccine coverage: Can newer-generation and locally produced vaccines help?Hum Vaccin Immunother. 2018 Feb 1;14(2):495-499. doi: 10.1080/21645515.2017.1403705. Epub 2017 Dec 21. Hum Vaccin Immunother. 2018. PMID: 29135339 Free PMC article. Review.
-
Prediction of promiscuous multiepitope-based peptide vaccine against RdRp of rotavirus using immunoinformatics studies.Rev Inst Med Trop Sao Paulo. 2024 Sep 6;66:e55. doi: 10.1590/S1678-9946202466055. eCollection 2024. Rev Inst Med Trop Sao Paulo. 2024. PMID: 39258658 Free PMC article.
-
Effects of Escherichia coli Nissle 1917 and Ciprofloxacin on small intestinal epithelial cell mRNA expression in the neonatal piglet model of human rotavirus infection.Gut Pathog. 2016 Dec 13;8:66. doi: 10.1186/s13099-016-0148-7. eCollection 2016. Gut Pathog. 2016. PMID: 27999620 Free PMC article.
-
Cost-Effectiveness of Rotavirus Vaccination for Under-Five Children in Iran.Iran J Pediatr. 2015 Aug;25(4):e2766. doi: 10.5812/ijp.2766. Epub 2015 Aug 24. Iran J Pediatr. 2015. PMID: 26396704 Free PMC article.
References
-
- Organization WH. Weekly Epidemiologic Record. Vol. 78. World Health Organization; 2003. Rotavirus vaccines, an update; pp. 2–3.http://www.who.int/wer
-
- GAVI Alliance GAVI and the Vaccine Fund announce $60 million boost to accelerate development of lifesaving vaccine. 2003 http://www.gavialliance.org/media_centre/press_releases/2003_02_11_en_pr...
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical